Ye Weiguo, the Chief Operating Officer of Gyre Therapeutics, has completed a stock sale amounting to $128,885. This transaction reflects a portion of his holdings in the company. The sale is part of standard financial activities typically undertaken by executives in publicly traded companies. Details regarding the specific number of shares sold or the reasons for the transaction have not been disclosed.
Related Articles
Don't miss out on breaking stories and in-depth articles.